Compound 374
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(cc1)-c1ccccc1)Cc1cccc(CNS(=O)(=O)c2ccc(cc2)C#N)c1
- InChi:
InChI=1S/C34H27Cl2N3O5S2/c35-30-18-32(36)34(40)33(19-30)46(43,44)39(22-25-9-13-29(14-10-25)28-7-2-1-3-8-28)23-27-6-4-5-26(17-27)21-38-45(41,42)31-15-11-24(20-37)12-16-31/h1-19,38,40H,21-23H2
- InChiKey:
NSIWNCVWKFYMMX-UHFFFAOYSA-N
External links
66634086 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 4 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.22 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 691.08 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 7.44 | |||
TPSA | 127.57 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 4 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.22 | |
WO2009152082 | 4 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.22 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5862 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4691 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4453 | Sulfabenzamide | DB09355 | |
0.4419 | Saccharin | DB12418 | |
0.4393 | 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid | DB03207 | |
0.4371 | N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE | DB04588 | |
0.4348 | Evatanepag | DB12022 | |
0.4252 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.4145 | AL5927 | DB03526 | |
0.4097 | THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE) | DB07363 | |
0.4056 | 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide | DB07162 | |
0.4016 | N-Benzyl-4-Sulfamoyl-Benzamide | DB01748 | |
0.3989 | 3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE | DB08487 | |
0.3961 | N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE | DB08270 | |
0.3949 | N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | DB08631 |